Advanced Genomics, LLC

Advanced Genomics, LLC was paid $364K by Medicaid between Jan 2018 and May 2024, across 40 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 71% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Texas

Rank by total paid#108 of 436

Median peer was paid$17K

This provider vs. median21×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	3,300	$0.00
2019	327	$80.53
2020	1,473	$29K
2021	45,915	$157K
2022	29,672	$177K
2024incomplete	12	$1K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	71%	19,912	6,261	$260K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	11%	19,462	6,016	$41K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	7.2%	18,334	5,658	$26K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	3.4%	382	266	$12K
87631		2.5%	7,701	2,651	$9K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	2.2%	448	311	$8K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	1,441	632	$3K
87581		<1%	1,747	823	$2K
87486		<1%	1,747	823	$2K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	12	12	$1K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	1,365	557	$444.10
87498		<1%	1,365	557	$298.43

28 more codes

87503		<1%	1,367	$85.90
87634		<1%	1,367	$70.20
80061	Lipid panel	<1%	70	$29.68
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	93	$29.40
87640		<1%	27	$23.94
87500		<1%	27	$23.94
87653		<1%	27	$23.94
87481		<1%	27	$23.94
87641		<1%	33	$23.94
80053	Comprehensive metabolic panel	<1%	67	$21.45
81231		0%	261	$0.00
81226		0%	261	$0.00
81225		0%	261	$0.00
81230		0%	261	$0.00
81227		0%	261	$0.00
81240		0%	261	$0.00
87505		0%	27	$0.00
84443	Thyroid stimulating hormone (TSH)	0%	26	$0.00
81328		0%	261	$0.00
81479	Unlisted molecular pathology procedure	0%	176	$0.00
81401		0%	259	$0.00
81355		0%	261	$0.00
81291		0%	261	$0.00
81402		0%	176	$0.00
81241		0%	261	$0.00
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	0%	182	$0.00
81408		0%	39	$0.00
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	0%	183	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWAY, DAVID (CEO)